Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 3.39% | 63.67 | 0.0% | $945.94m | |
| NVAX | Novavax, Inc. | 0.07% | 98.37 | 102.0% | $791.03m | |
| AMGN | Amgen, Inc. | -0.03% | 251.51 | 1.3% | $725.02m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.33% | 638.25 | 2.5% | $675.43m | |
| GILD | Gilead Sciences, Inc. | -0.99% | 74.87 | 1.0% | $621.03m | |
| BIIB | Biogen, Inc. | -1.17% | 276.92 | 1.6% | $615.33m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.94% | 293.13 | 1.9% | $504.20m | |
| ILMN | Illumina, Inc. | 0.89% | 373.17 | 3.5% | $302.74m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.37% | 107.60 | 2.0% | $218.66m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.75% | 126.48 | 4.3% | $210.56m | |
| SGEN | Seattle Genetics, Inc. | 3.49% | 181.66 | 6.1% | $207.20m | |
| SRNE | Sorrento Therapeutics, Inc. | 2.31% | 7.46 | 1.8% | $184.35m | |
| IMMU | Immunomedics, Inc. | 2.07% | 42.41 | 11.0% | $183.18m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.43% | 169.42 | 13.9% | $164.25m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -1.58% | 157.89 | 8.5% | $161.47m |
Company Profile
IMV, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of immunotherapies for the treatment of infectious diseases. Its proprietary drug delivery platform DPX develops a pipeline of novel therapeutic and preventive approaches for cancer and other serious diseases. The company was founded by Warwick Kimmins and Brian E. Lowe on March 28, 2000 and is headquartered in Dartmouth, Canada.